Author

T. Bowman

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:benchmark study· 1 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

A. Pellagatti· 1 shared A. Shastri· 1 shared A. Verma· 1 shared A. Wickrema· 1 shared A. Yeaton· 1 shared B. A. Goods· 1 shared B. Agianian· 1 shared B. Will· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Pellagatti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues

H. Wang, R. Huang, J. Nelson, C. Gao, M. Tran, A. Yeaton, K. Felt, K. L. Pfaff, T. Bowman, S. J. Rodig, K. Wei, B. A. Goods, S. L. Farhi

This study benchmarks three imaging spatial transcriptomics platforms on FFPE tissues, finding 10x Xenium has higher transcript counts without sacrificing specificity, while all platforms align with RNA-seq data but vary in performance metrics.

bioRxiv · Dec 7, 2023Cancer Biology

Activation of targetable inflammatory immune signaling is seen in Myelodysplastic Syndromes with SF3B1 mutations

G. Choudhary, A. Pellagatti, B. Agianian, M. Smith, T. D. Bhagat, S. Gordon-Mitchell, S. Pandey, N. Shah, S. Aluri, L. Schwartz, V. Steeples, R. Booher, M. Ramachandra, M. Samson, M. Carbajal, , A. Verma

This study identifies a longer, oncogenic IRAK4 isoform caused by SF3B1 mutations in MDS/AML, which is targetable by IRAK4 inhibition.

bioRxiv · Mar 9, 2022Cancer Biology